Novel allogeneic stem cells and differentiated iPSCs are providing more physiologically relevant disease models.

In a first-of-its-kind clinical trial, UCLA scientists have shown it's possible to reprogram a patient's blood-forming stem ...

When most veterinarians hear the term "stem cell therapy," their minds often go to autologous procedures – tissue harvested ...

The itching, redness and swelling of an allergic reaction are caused by mast cells—the vigilant first responders of the ...

July is Cord Blood Awareness Month, highlighting the benefits of umbilical cord blood for treating diseases like leukemia.

Florida has allowed stem cell treatments that the US FDA does not approve. Here's everything we know about these therapies.

PSC-derived exosomes (iPSC-Exos) are rich in bioactive molecules and have demonstrated promising effects in cardiovascular ...

In hypoxic pulmonary hypertension, exosomes derived from stem cells may be a therapy option for preventing abnormal muscle ...

We can then turn those cells into beating heart cells and use them later in treating congenital heart defects,” the study’s senior author said.

The global allogeneic cell therapy market is set to witness a growth rate of 25% in the next 5 years. Growing demand for ...

Dr. Amir Kol realized the striking parallels between FIP and severe COVID-19 could offer hope for millions of long COVID ...

Elenagen™, a novel DNA plasmid therapy that previously demonstrated high clinical benefit and low toxicity in cancer patients, has now shown significant promise in alleviating chronic pain ...